SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?


To: Mark Marcellus who wrote (3974)11/6/2001 9:08:20 AM
From: DanZ  Read Replies (2) | Respond to of 5582
 
I didn't say that Swedish Match didn't want out of the joint venture. I said that it was mutually agreeable. You made it sound like Gum Tech didn't want out and it was only Swedish Match that wanted out. Gum Tech could have fulfilled its obligation to the joint venture, but Swedish Match apparently doesn't want Wrigley to make the gum. Notice that Swedish Match said that there are other players in the market that they can team with. Doesn't that alone tell you that they don't have the capability to formulate and manufacture gum? You belittle everything about Gum Tech when in reality they possess a capability that Swedish Match found attractive. It isn't simply putting machines in a room to make gum. They wanted Gum Tech primarily for their R&D. If you would give Gum Tech credit where credit is due I wouldn't have a problem with your differing opinion. You simply try to discredit this company in every way possible and your bias does not foster an open discussion.

Regarding profitability, yes I have been wrong about how long it would take. I expected the Swedish Match joint venture to launch products by now. If they had, the stock would be much higher, Gum Tech probably wouldn't have sold their gum manufacturing, and my predictions would have come true. Gum Tech had nicotine gum products ready to go months ago. Swedish Match took too long to get their marketing plans together. It is clear to me that this played into Gum Tech's decision to sell their manufacturing to Wrigley. Isn't it obvious from reading Bo Aulin's comments that they only decided to dissolve the joint venture with Gum Tech after Gum Tech sold their gum manufacturing? They would have been content riding Gum Tech along for another year or whatever until they were ready to launch a product. As a Gum Tech Shareholder, I am glad that they sold the gum business and are getting rid of Swedish Match. That company hasn't fulfilled its goals to the joint venture and has hurt Gum Tech's stock price. I say good riddance to them and look forward to the new partner who I believe will be more motivated to launch a product. The nicotine gum market is still growing about 20% per year and is nearly $1 billion in sales strong. When and if Gum Tech announces that they are launching a product, and if they own a similar proportion of the business as they did with Swedish Match, this stock will be back in the 20s in no time.

Gel Tech was profitable last quarter. The only reason that Gum Tech recorded a 1 cent per share loss is because of the 40% minority payment. After they close on the deal with Zengen, they won't have to pay that 40% any more. Therefore, on a proforma basis, Gum Tech was profitable last quarter and I expect that they will be profitable for at least the next two quarters. Your comment about Zicam Allergy relief is without merit. How do you know how well it is selling? It must be selling reasonably well because it is a finalist for the Retail Excellence Award.